Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › RSV infection

RSV infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for RSV infection

10 trials tracked for RSV infection: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 14 citations.

10Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 3 Phase 1 4 Other / NA 2
  1. Phase 3 Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) Completed · 14 cited
  2. Phase 2 A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model Completed
  3. Phase 2 Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children Completed
  4. Phase 2 A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model Completed
  5. Phase 1 Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children Completed
  6. Phase 1 Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children Completed
Show 4 more trials
  1. Phase 1 Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age Completed
  2. Phase 1 Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults Completed
  3. N/A Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis Completed
  4. N/A The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
RSV infection complicated by acute otitis media in 27.7% of children under 5
Pediatrics Meta-analysis
RSV infection complicated by acute otitis media in 27.7% of children under 5 RSV infection often leads to middle ear infections in children
This meta-analysis of children aged 0-60 months found that 27.7% of RSV infections are complicated by acute otitis media (AOM), and RSV is d…
Nearly 28% of children with RSV infections develop a middle ear infection, which is often complicated by bacterial growth.
Jun 27, 2026